Transgene Financial Overview
Transgene's market cap is currently €261.85M. The company's EPS TTM is €; its P/E ratio is -3.38; Transgene is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.